Srinibas Pradhan Constructions IPO...
28 Feb, 2026
Ambey Laboratories Limited IPO
Ambey Laboratories is engaged in the business of manufacturing agrochemical products to protect crops and it’s been almost four decades since the company served the agrochemical sector. The Company is a manufacturer and supplier of “2, 4-D base chemicals” with the highest quality practice and compliant with the chemical industry's Highest Environmental, Health and Safety. The company has a Programmable Logic Controller and Supervisory Control along with a Quality Assurance Department that ensures testing through HPLC, GC, UV, etc. Ambey Laboratories IPO is a book-built issue of Rs 46.68 crores.
The issue is a fresh issue of 65.52 lakh shares aggregating to Rs 44.55 crores and an offer for sale of 3.12 lakh shares aggregating to Rs 2.12 crores. Ambey Laboratories IPO opens for subscription on July 4, 2024 and closes on July 8, 2024. The allotment for the Ambey Laboratories IPO is expected to be finalized on Tuesday, July 9, 2024. Ambey Laboratories IPO price band is set at ₹65 to ₹68 per share. The minimum lot size for an application is 2000 Shares. Fast Track Finsec Pvt Ltd is the book-running lead manager of the Ambey Laboratories IPO, while Link Intime India Private Ltd is the registrar for the issue. The market maker for Ambey Laboratories IPO is Nikunj Stock Brokers.
WHAT IS GMP?
GMP (Grey Market Premium) is the difference between the IPO price and the grey market price. It is the premium amount paid for the traded IPO shares. It plays an important role in IPOs as it reflects how the IPO would react on the listing day.
A grey market is a place where shares/stocks are traded before being listed officially on the stock exchange.
Ambey Laboratories Limited IPO GMP
| GMP Date | IPO Price | GMP | Last Updated |
|---|---|---|---|
| - | - | - | - |
**The GMP prices displayed here are solely for informational purposes related to the grey market news. India IPO does not engage in or facilitate grey market trading, nor are these rates (sub2) indicative of any trading activity. We also do not recommend or endorse participation in the grey market.**
Ambey Laboratories Limited IPO Details
| Detail | Description |
|---|---|
| IPO Date | July 3, 2024 to July 5, 2024 |
| Listing Date | [.] |
| Face Value | ₹10 per share |
| Price Band | ₹65 to ₹68 per share |
| Lot Size | 2000 Shares |
| Total Issue Size | 6,864,000 shares (aggregating up to ₹46.68 Cr) |
| Fresh Issue | 6,552,000 shares (aggregating up to ₹44.55 Cr) |
| Offer for Sale | 312,000 shares of ₹10 (aggregating up to ₹2.12 Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | NSE SME |
| Shareholding pre issue | 18,688,819 |
| Shareholding post issue | 25,240,819 |
| Market Maker portion | 312,000 shares Nikunj Stock Brokers |
Ambey Laboratories Limited IPO Timeline
| Detail | Description |
|---|---|
| IPO Open Date | Thursday, July 4, 2024 |
| IPO Close Date | Monday, July 8, 2024 |
| Basis of Allotment | Tuesday, July 9, 2024 |
| Initiation of Refunds | Wednesday, July 10, 2024 |
| Credit of Shares to Demat | Wednesday, July 10, 2024 |
| Listing Date | Thursday, July 11, 2024 |
| Cut-off time for UPI mandate confirmation | 5 PM on July 8, 2024 |
Ambey Laboratories Limited IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 2000 | ₹136,000 |
| Retail (Max) | 1 | 2000 | ₹136,000 |
| HNI (Min) | 2 | 4,000 | ₹272,000 |
Ambey Laboratories IPO Reservation
| Investor Category | Shares Offered |
|---|---|
| QIB Shares Offered | Not more than 50% of the Net Issue |
| Retail Shares Offered | Not less than 35% of the Net Issue |
| NII (HNI) Shares Offered | Not less than 15% of the Net Issue |
Ambey Laboratories Limited IPO Promoter Holding
| Share Holding Pre Issue | Share Holding Post Issue |
|---|---|
| 94.97% | 69.90% |
Ambey Laboratories IPO Anchor Investors Details
| Bid Date | July 3, 2024 |
| Shares Offered | 1,872,000 |
| Anchor Portion Size (In Cr.) | 12.73 |
| Anchor lock-in period end date for 50% shares (30 Days) | August 8, 2024 |
| Anchor lock-in period end date for remaining shares (90 Days) | October 7, 2024 |
Competitive Strength:
- -
Ambey Laboratories Limited IPO Financial Information
| Period Ended | Assets | Total Income | Profit After Tax | Net Worth | Reserves and Surplus | Total Borrowing | ||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 31 Jan 2024 | 8,620.84 | 10,043.69 | 607.73 | 3,431.34 | - | 2,005.44 | ||||||||||||||||||||||||||||||||||
| 31 Mar 2023 | 5,761.85 | 10,743.47 | 456.93 | 2,363.60 | - | 1,365.22 | ||||||||||||||||||||||||||||||||||
| 31 Mar 2022 | 5,592.94 | 8,511.19 | 357.47 | 1,906.67 | - | 1,804.86 | ||||||||||||||||||||||||||||||||||
| 31 Mar 2021 | 4,461.80 | 8,241.54 | 1,033.67 | -786.39 | - | 3,292.98 | ||||||||||||||||||||||||||||||||||
| Amount in ₹ Crore | ||||||||||||||||||||||||||||||||||||||||
Key Performance Indicator
| KPI | Values |
|---|---|
| ROE | 20.80% |
| ROCE | 13.14% |
| Debt/Equity | 0.58 |
| RoNW | 20.80% |
| P/BV | 3.58 |
| PAT Margin (%) | 6.01 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (Rs) | 2.44 | 2.89 |
| P/E (x) | 27.81 | 23.54 |
Objectives of Ambey Laboratories IPO
-
The company intends to utilize the Net Proceeds for the following objectives:
- ● To meet Working Capital Requirements
- ● General corporate purposes
- ● Issue related expenses
Ambey Laboratories IPO Review
The company is operating in a highly competitive and fragmented segment of agrochemicals. It has posted inconsistency in its bottom lines for the reported periods. There is some garble in the offer documents on financial data. Based on FY24 annualized super earnings, the issue appears aggressively priced, discounting all near-term positives. There is no harm in skipping this “High Risk/Low Return” bet.
RHP:
View RHPDRHP:
View DRHPRead more :
- Bulkcorp International Limited IPO
- Sathlokhar Synergys E&C Global Limited IPO
- Vdeal System Limited IPO And Its GMP
Frequently Asked Questions (FAQs)
-
What is Ambey Laboratories IPO?
Ambey Laboratories IPO is an NSE SME IPO. They are going to raise ₹46.68 Crores via IPO. The issue is priced at ₹65 to ₹68 per equity share. The IPO is to be listed on NSE.
-
When will Ambey Laboratories IPO open?
The IPO is to open on July 4, 2024 for QIB, NII, and Retail Investors.
-
What is Ambey Laboratories IPO Investors Portion?
The investors’ portion for QIB is 50%, NII is 15%, and Retail is 35%.
-
What is Ambey Laboratories IPO Size?
Ambey Laboratories IPO size is ₹46.68 crores.
-
What is Ambey Laboratories IPO Price Band?
Ambey Laboratories IPO Price Band is ₹65 to ₹68 per equity share.
-
What is Ambey Laboratories IPO Minimum and Maximum Lot Size?
The IPO bid is 2000 shares with ₹136,000.
-
What is Ambey Laboratories IPO Allotment Date?
Ambey Laboratories IPO allotment date is July 9, 2024.
